Board members can access materials for upcoming board meetings by clicking here. (Special Board member login required.)
Jennifer Lund, FISPE
Associate Professor, Department of Epidemiology
University of North Carolina at Chapel Hill
Chapel Hill, USA
Serving first 3-year term
Stine Hasling Mogensen
Senior Advisor
Danish Medicines Agency's Data Analytic Centre
Copenhagen, Denmark
Serving first 3-year term
Daniel Prieto-Alhambra, FISPE
Professor of Pharmaco- and Device Epidemiology
Centre for Statistics in Medicine
Oxford, UK
Serving first 3-year term
Yoshiaki Uyama
Director, Office of Medical Informatics and Epidemiology
Pharmaceuticals and Medical Devices Agency (PMDA)
Tokyo, Japan
Serving first 3-year term
Hongbo Yuan
Scientific Advisor, Evidence Standard
Canadian Agency for Drugs and Technologies in Health
Ottawa, Canada
Serving first 3-year term
Gillian Caughey
Associate Director/Adjunct A/Professor
Registry of Senior Australians (ROSA), Healthy Ageing Research Consortium, South Australian Health and Medical Research Institute
Adelaide, Australia
Serving first 3-year term
Efe Eworuke
Associate Director, Science
Office of Pharmacovigilance and Epidemiology
Office of Surveillance and Epidemiology
Center for Drug Evaluation and Research, US FDA
Silver Spring, Maryland, USA
Serving first 3-year term
Jessica Franklin
Principal Consultant, Epidemiology and Real-World Evidence
Optum
Boston, Massachusetts, USA
Serving first 3-year term
Ursula Kirchmayer, FISPE
Pharmacoepidemiologist
Department of Epidemiology, ASL Roma1,
Lazio Regional Health Service
Rome, Italy
Serving second 3-year term
Andrea Margulis, FISPE
Director, Epidemiology RTI Health Solutions
RTI International
Barcelona, Spain
Serving first 3-year term
Keiko Asao
IQVIA Solutions Japan KK
Tokyo, Japan
Serving first 3-year term
Marianne Cunnington
Analysis Group Inc.
London, UK
Serving first 3-year term
Mette Nørgaard
Professor in Epidemiology of Urinary Tract Diseases, Department of Clinical Epidemiology
Aarhus University
Denmark
Serving second 3-year term
Elisabetta Patorno, FISPE
BWH Div of Pharmacoepidemiology and Pharmacoeconomics
Boston, Massachusetts, USA
Serving first 3-year term
Jeremy Rassen, FISPE
Co-Founder, President and Chief Science Officer
Aetion, Inc.
New York, NY
Serving second 3-year term
Stanley A. Edlavitch, FISPE
University of Missouri School of Medicine
Kansas City, USA